Advancing findings highlight the compound, a double activator for GLP-1 and GIP, demonstrate encouraging capability in managing obesity and associated metabolic states. Initial studies show considerable fat reduction https://retatrutideresearchlab.co.uk/product/ozempic-025-mg-peptide/